Oral PSORI-CM01, a Chinese herbal formula, plus topical sequential therapy for moderate-to-severe psoriasis vulgaris: pilot study for a double-blind, randomized, placebo-controlled trial

@inproceedings{Yao2016OralPA,
  title={Oral PSORI-CM01, a Chinese herbal formula, plus topical sequential therapy for moderate-to-severe psoriasis vulgaris: pilot study for a double-blind, randomized, placebo-controlled trial},
  author={Dan-ni Yao and Chuan-jian Lu and Ze-huai Wen and Yu-hong Yan and Mei-ling Xuan and Xiao-yan Li and Geng Li and Ze-hui He and Xiu-li Xie and Jing-wen Deng and Xin-feng Guo and Ai-hua Ou},
  booktitle={Trials},
  year={2016}
}
BACKGROUND To provide evidence that the Chinese herbal medicine (CHM) PSORI-CM01 combined with Western medicine reduces the relapse rate of psoriasis vulgaris (PV), we plan to conduct a large-scale randomized control trial (RCT). In order to improve and perfect the RCT, this pilot study was designed to determine the feasibility and the potential of a modified protocol for the full-scale RCT. METHODS Eligible patients with psoriasis vulgaris (PV) were enrolled into a randomized comparison in… CONTINUE READING
BETA
2
Twitter Mentions

Figures, Tables, and Topics from this paper.

Citations

Publications citing this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 20 REFERENCES

S3 - Guidelines on the treatment of psoriasis vulgaris (English version). Update.

  • Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
  • 2012
VIEW 2 EXCERPTS

Effects of Yinxieling-optimization-decoction in treating psoriasis in mouse psoriasis models

  • 2011 IEEE International Conference on Bioinformatics and Biomedicine Workshops (BIBMW)
  • 2011
VIEW 1 EXCERPT

Similar Papers

Loading similar papers…